Accuray (NASDAQ:ARAY) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Accuray (NASDAQ:ARAY – Get Rating) in a report released on Thursday morning. The firm issued a hold rating on the medical equipment provider’s stock.

Accuray Trading Down 1.8 %

NASDAQ:ARAY opened at $2.80 on Thursday. The company has a debt-to-equity ratio of 3.36, a quick ratio of 0.98 and a current ratio of 1.82. The firm has a market cap of $267.40 million, a price-to-earnings ratio of -21.54 and a beta of 1.51. Accuray has a 52 week low of $1.70 and a 52 week high of $3.67. The firm has a 50-day moving average price of $2.75 and a two-hundred day moving average price of $2.33.

Accuray (NASDAQ:ARAY – Get Rating) last posted its quarterly earnings data on Wednesday, February 1st. The medical equipment provider reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.01. The firm had revenue of $114.76 million during the quarter, compared to analyst estimates of $106.28 million. Accuray had a negative net margin of 2.83% and a negative return on equity of 23.23%. On average, equities analysts expect that Accuray will post -0.05 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Accuray

Several large investors have recently modified their holdings of the stock. Teton Advisors Inc. increased its stake in shares of Accuray by 14.3% during the 1st quarter. Teton Advisors Inc. now owns 40,000 shares of the medical equipment provider’s stock worth $132,000 after purchasing an additional 5,000 shares during the last quarter. Atria Wealth Solutions Inc. increased its stake in shares of Accuray by 26.0% during the 4th quarter. Atria Wealth Solutions Inc. now owns 29,100 shares of the medical equipment provider’s stock worth $61,000 after purchasing an additional 6,000 shares during the last quarter. Sei Investments Co. increased its stake in shares of Accuray by 22.7% during the 1st quarter. Sei Investments Co. now owns 33,609 shares of the medical equipment provider’s stock worth $89,000 after purchasing an additional 6,218 shares during the last quarter. Mackenzie Financial Corp increased its stake in shares of Accuray by 36.9% during the 2nd quarter. Mackenzie Financial Corp now owns 26,627 shares of the medical equipment provider’s stock worth $52,000 after purchasing an additional 7,171 shares during the last quarter. Finally, Rafferty Asset Management LLC increased its stake in shares of Accuray by 47.0% during the 2nd quarter. Rafferty Asset Management LLC now owns 26,905 shares of the medical equipment provider’s stock worth $53,000 after purchasing an additional 8,597 shares during the last quarter. Hedge funds and other institutional investors own 63.42% of the company’s stock.

Accuray Company Profile

(Get Rating)

Accuray, Inc is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy.